Qijian News_News_Qijian Bio-Pharmaceutical Co.,Ltd.

API (Butylphthalein) R&D Site, Production Site Verification and GMP Compliance Inspection of Jilin Qijian Bio-Pharmaceutical Co.,Ltd successfully passed.

26 2023/09

CPHI Worldwide will be held in Barcelona, Spain on October 24-26, 2023.Jilin Qijian Bio-Pharmaceutical Co.,Ltd will attend the exhibition, Booth No: 80Q19, welcome to visit us.

26 2023/09

Great News! Qijian has obtained the human growth hormone (HGH) API export license signed and approved by the Food and Drug Administration。

In early 2022, Jilin Provincial Food and Drug Administration announced our "Drug export license for anabolic agents and peptide hormones" on website, it means that Qijian has become an approved enterprise for export human growth hormone (HGH) API in Jilin Province. Moreover in April 2021 Qijian obtained the "Drug Production License" for product HGH which updated and issued by CFDA, and the quality of HGH products meet the US FDA and EU GMP standards. In the new year, we will continue to improve our management level and provide customers with better products. 注：出口准许证获批公示连接地址吉林省药品监督管理局核（换）发《药品生产许可证》公告（2022年第1期）公示连接地址药品生产许可查询地址

24 2022/01

Great News! Qijian has obtained the human growth hormone (HGH) API export license signed and approved by the Food and Drug Administration。

Jilin Qijian Bio-Pharmaceutical Co., Ltd. participated in the 2023CPHI Southeast Asia Exhibition

CPHI South East Asia 2023 has been held at Queen Sirikit National Convention Center, Bangkok, Thailand from July 12-14, 2023.

17 2023/07

Jilin Qijian Bio-Pharmaceutical Co., Ltd. participated in the 2023CPHI Southeast Asia Exhibition

Legal Statement

We solemnly declare: Registered Chinese website of our company: www.qjbio.com.cn， Registered English website of our company：www.qijianbio.com, Contact information Phone: 0086-431-81285900 Fax: 0086-431-88794098 Mobile: 0086-18543117394 E-mail: export@qijianbio.com Furthermore, our company does not register or use other websites, and we also don’t authorize anyone to register or use other websites. Please distinguish truth from falsehood, beware of being cheated!

31 2022/10

ijian Bio-pharmaceutical made a major breakthrough in the R&D of key transdermal technology using HGH analogue peptides as raw materials for medical beauty products, laying a good foundation for the company to expand the medical beauty industry in 2021.

ijian Bio-pharmaceutical made a major breakthrough in the R&D of key transdermal technology using HGH analogue peptides as raw materials for medical beauty products, laying a good foundation for the company to expand the medical beauty industry in 2021.

01 2021/12